
Q-Siz 25 Tablet
Marketer
Tripada Biotec Pvt Ltd
Salt Composition
Quetiapine (25mg)
Overview Q-Siz 25 Tablet
Q-Siz 25mg tablets treat schizophrenia (a mental illness causing hallucinations, delusions, and impaired thinking/behavior) and manic episodes. They're also used for bipolar disorder. This medication can be taken with or without food, but consistent daily timing ensures stable blood levels. Follow your doctor's prescribed dosage and duration. If a dose is missed, take it immediately upon recall. Sudden cessation is dangerous and may exacerbate symptoms; consult your doctor before stopping. Immediately discontinue if Neuroleptic Malignant Syndrome (NMS) occurs (fever, muscle stiffness, altered awareness, or seizures). Common side effects include low hemoglobin, high triglycerides, low cholesterol, headache, extrapyramidal symptoms, dry mouth, and withdrawal symptoms. Postural hypotension (sudden blood pressure drop upon standing) may occur initially; rise slowly. Dizziness and drowsiness are possible; avoid driving or mentally demanding tasks until effects are known. Weight gain is a potential side effect, mitigated by diet and exercise. Increased diabetes risk necessitates regular glucose monitoring. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your physician immediately.
Primary Ingredients of Q-Siz 25 Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Q-Siz 25 Tablet
Managing Manic Episodes | Treating Schizophrenia
Major Benefits of Q-Siz 25 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Q-Siz 25 Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Q-Siz 25 Tablet:
- Weight gain
- Constipation
- Dizziness
- Dryness in mouth
- Fatigue
- High blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Sleepiness
- Dyslipidemia
- Increased appetite
How to use Q-Siz 25 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Q-Siz 25 Tablets can be consumed with or without food, though consistent timing is recommended.
How Q-Siz 25 Tablet works:
Q-Siz 25 mg tablets contain an atypical antipsychotic medication that alters the activity of specific neurotransmitters influencing cognitive processes.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while taking Q-Siz 25 Tablets.
PregnancyCONSULT YOUR DOCTOR
The use of Q-Siz 25 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to any prescription. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
The use of Q-Siz 25 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Q-Siz 25 Tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Q-Siz 25 Tablet appears to be well-tolerated by individuals with kidney impairment. Preliminary findings indicate that dosage modification may not be necessary for this population. However, physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Q-Siz 25 Tablet cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Q-Siz 25 Tablet :
Should you forget a Q-Siz 25 Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Q-Siz 25 Tablet
| Label | Value |
|---|---|
| Chemical Category | Dibenzothiazepine Compounds |
| Developing Habits | No. |
| Treatment Category | Neuroscience (CNS) |
